News

In the podcast, Prof. Dr. Johannes Mosbacher and Prof. Dr. Stefan Gaugler philosophize about the current status of laboratory automation and digitalization in the Bachelor’s and Master’s degree courses at the FHNW and talk about future trends.

Andrea joined the ICB on March 1st.  Find out about her research activities and interests here.

Her three-minute talk got the audience’s attention by drawing similarities between liver fibrosis and football!

The Cell Biology and In Vitro Toxicology group recently published the results of their investigation in the journal Toxicology

Lena obtained her Dr. rer nat with a magna cum laudae for her work on neural regeneration after spinal cord injury, supervised in part by Laura Suter-Dick

Timon joined the ICB on January 15th.  Find out about his research activities and interests here.

On December 13, 2024 in Bern, Prof. Dr. Laura Suter-Dick presented state-of-the-art methodologies and chaired a session at the 3RCC symposium on Successfully Implementing New Approach Methodologies: Practical Applications in Drug Development and Clinical Practice.

The in vitro model helps close the knowledge gap in metabolism and systemic toxicity of glycol ethers and may support the safety assessment of solvents with relevant occupational exposures.

The study on Sustainability in HLS Laboratory Operations aims to reduce energy and resource use in the labs significantly, via measures that can be seamlessly integrated into everyday lab work.

The Molecular nanotechnology group, supported by the Cell biology group, published their work in the journal RSC Nanoscale Advances.

The team isolated 18 compounds, one of which was reported for the first time as a genuine natural product showing cytotoxic activity.